Nature communications · 2018
Linked dimensions of psychopathology and connectivity in functional brain networks.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xia Cedric Huchuan, Ma Zongming, Ciric Rastko, Gu Shi, Betzel Richard F, Kaczkurkin Antonia N, Calkins Monica E, Cook Philip A, García de la Garza Angel, Vandekar Simon N, Cui Zaixu, Moore Tyler M, Roalf David R, Ruparel Kosha, Wolf Daniel H, Davatzikos Christos, Gur Ruben C, Gur Raquel E, Shinohara Russell T, Bassett Danielle S, Satterthwaite Theodore D
Аннотация
Neurobiological abnormalities associated with psychiatric disorders do not map well to existing diagnostic categories. High co-morbidity suggests dimensional circuit-level abnormalities that cross diagnoses. Here we seek to identify brain-based dimensions of psychopathology using sparse canonical correlation analysis in a sample of 663 youths. This analysis reveals correlated patterns of functional connectivity and psychiatric symptoms. We find that four dimensions of psychopathology - mood, psychosis, fear, and externalizing behavior - are associated (r = 0.68-0.71) with distinct patterns of connectivity. Loss of network segregation between the default mode network and executive networks emerges as a common feature across all dimensions. Connectivity linked to mood and psychosis becomes more prominent with development, and sex differences are present for connectivity related to mood and fear. Critically, findings largely replicate in an independent dataset (n = 336). These results delineate connectivity-guided dimensions of psychopathology that cross clinical diagnostic categories, which could serve as a foundation for developing network-based biomarkers in psychiatry.